All Pathways
Infectious DiseaseEmergency

Septic Arthritis Management

Septic Arthritis Management: Suspected septic arthritis (adult, native joint) → Child or prosthetic joint: use a different pathway → Urgent joint aspira...

Pathway Overview

18 steps

Algorithm Steps

18 total

  1. 01Start

    Suspected septic arthritis (adult, native joint)

    Acute hot, swollen, painful joint. Fever can be absent. Treat as an emergency.

  2. 02Warning

    Child or prosthetic joint: use a different pathway

    This pathway is for adults with a native joint.

    • Child: paediatric pathway. Under 5 years, cover Kingella kingae (vancomycin does not)
    • Prosthetic joint: urgent orthopaedic and ID referral; prosthetic joint infection pathway
    • ACL graft or other joint implant: orthopaedic advice before treatment
  3. 03Action

    Urgent joint aspiration before antibiotics

    Sepsis or septic shock: take blood cultures and start antibiotics now. Do not wait for aspiration.

    • Synovial fluid: Gram stain, culture, WBC count, crystals
    • Blood cultures: 2 sets
    • Hip, shoulder, sacroiliac or deep joint: image-guided aspiration (ultrasound, fluoroscopy or CT)
    • Aseptic technique. Do not aspirate through a skin abscess; avoid overlying cellulitis if possible
    • Put spare fluid into blood culture bottles
    • Bloods: FBC, CRP, urea, electrolytes and creatinine
  4. 04Warning

    Synovial results cannot exclude septic arthritis

    Treat on clinical suspicion.

    • WBC >50,000/µL (50 x10^9/L) suggests infection but does not prove it
    • WBC <25,000/µL (25 x10^9/L) lowers the chance but does not exclude it, mainly if immunosuppressed
    • Crystals or a negative Gram stain do not exclude infection
  5. 05Warning

    Tropical northern Australia: think of melioidosis before empiric antibiotics

    B. pseudomallei causes septic arthritis in the tropical north, mainly in the wet season. Ceftriaxone and flucloxacillin do not treat it.

    • Risk factors: diabetes, hazardous alcohol use, chronic kidney or lung disease, immunosuppression
    • Suspected melioidosis, or gram-negative bacilli on Gram stain in this setting: meropenem 1 g IV 8-hourly (adult); get ID advice
    • Tell the lab that melioidosis is possible (laboratory hazard)
  6. 06Action

    Empiric IV antibiotics (adult) after aspiration

    Sepsis or septic shock: give antibiotics now by the local sepsis guideline (septic shock: add vancomycin). Severe penicillin allergy (anaphylaxis, SJS/TEN or DRESS): no beta-lactam. Renal impairment: adjust cefazolin and vancomycin doses. Tropical north: see melioidosis warning.

    • No penicillin allergy: flucloxacillin 2 g IV 6-hourly (not if past flucloxacillin jaundice or hepatitis)
    • Penicillin allergy: non-severe, cefazolin 2 g IV 8-hourly; severe, vancomycin IV instead (dose: local AUC-guided protocol)
    • MRSA risk: add vancomycin IV to flucloxacillin or cefazolin (do not replace them)
    • Gram-negative bacilli on Gram stain, or high gram-negative risk (immunocompromise, older age): add ceftriaxone 2 g IV daily (severe penicillin allergy: ID advice for a non-beta-lactam). Pseudomonas or resistant gram-negative risk (for example injecting drug use, recent hospital care): ceftriaxone does not cover these; get ID advice
    • Suspected gonococcal infection: add ceftriaxone 1 g IV daily to the anti-staphylococcal drug; give it alone only if Gram stain shows gram-negative diplococci. Severe penicillin allergy: ID or sexual health advice
    • Choose by Gram stain and local guidelines (eTG). Stop antibiotics if another diagnosis is confirmed
  7. 07Action

    Drain every septic joint: orthopaedic review now

    Large joint, hip or sepsis: surgical washout. Small accessible joint without sepsis: needle aspiration may be enough.

    • Surgical washout: arthroscopic for most early disease; open surgery for advanced joint damage
    • Sepsis or septic shock: surgery without delay
    • No sepsis: surgery can wait up to 24 h only if the joint is aspirated and irrigated, antibiotics have started and an experienced surgeon is available
    • Small accessible joint without sepsis, if orthopaedics agree: repeat needle aspiration each time fluid reaccumulates; no improvement: surgical washout
    • At surgery: send synovial biopsies for culture and histology
  8. 08Decision

    Culture result: which organism?

    Change to targeted therapy when the organism and susceptibilities are known.

  9. S. aureus
  10. 09Action

    S. aureus: targeted therapy

    Most common cause in adults.

    • MSSA: flucloxacillin 2 g IV 6-hourly (non-severe penicillin allergy: cefazolin 2 g IV 8-hourly)
    • MSSA with severe penicillin allergy: vancomycin IV (local AUC-guided protocol); ID or allergy advice
    • MRSA: vancomycin IV (local AUC-guided protocol); ID advice
    • Positive blood cultures: manage as S. aureus bacteraemia (echocardiography, ID consult); duration is longer
  11. 10Action

    Oral step-down and duration (all organisms)

    Set the total duration with ID advice. Longer if bacteraemia, osteomyelitis or slow response.

    • Switch to oral when fever, joint signs and CRP improve; choose a drug with good oral absorption
    • SANJO: IV usually 1-2 weeks, then oral 2-4 weeks
    • One RCT (mostly hand and wrist, after surgical washout) found 2 weeks as effective as 4 weeks. Large joint: set duration with ID advice
    • Gonococcal: at least 7 days in total
    • Mobilise early once infection is controlled
    • Long flucloxacillin course: check liver function periodically (cholestatic hepatitis, more common over 55 years)
  12. 11Decision

    Responding to treatment?

    Review pain, joint signs, fever, WBC and CRP every day.

  13. If Yes
    1. 12Outcome

      Responding: complete the course

      Follow up joint function. Refer for physiotherapy.

    If No
    1. 13Warning

      Not responding: treatment failure

      Act early. Involve orthopaedics and ID.

      • Re-aspirate the joint, or repeat surgical washout
      • Image (MRI) for abscess or osteomyelitis
      • Review organism, antibiotic, dose and duration
  14. Streptococcus
  15. 14Action

    Streptococcus: targeted therapy

    Second most common cause.

    • Benzylpenicillin IV, or ceftriaxone IV. Dose: see eTG Antibiotic
    • Severe penicillin allergy: vancomycin IV (local AUC-guided protocol); ID advice
  16. Path rejoins step 10Shared downstream outcome
  17. N. gonorrhoeae
  18. 15Action

    Gonococcal (disseminated gonococcal infection): ceftriaxone

    Severe penicillin allergy: get specialist advice before ceftriaxone. Pregnant: do not give doxycycline; get sexual health advice. New murmur, headache or neck stiffness: look for endocarditis or meningitis (higher dose, longer course; ID advice).

    • Ceftriaxone 1 g IV or IM every 24 h
    • Australia: also give azithromycin 1 g orally once (ASHM dual therapy for gonorrhoea); get sexual health or ID advice
    • After 24-48 h of clear improvement: oral switch by susceptibility; total at least 7 days
    • No azithromycin given and chlamydia not excluded (not pregnant): doxycycline 100 mg orally twice daily for 7 days
    • Sexual health referral: test for other STIs; partner notification
  19. Path rejoins step 10Shared downstream outcome
  20. Gram-negative
  21. 16Action

    Gram-negative bacilli: targeted therapy

    Treat by susceptibility with ID advice.

    • Look for a source (for example urinary tract)
    • B. pseudomallei (melioidosis): meropenem IV plus trimethoprim-sulfamethoxazole; at least 4 weeks IV, then months of oral eradication; ID advice
    • Pseudomonas or resistant organism: ID advice for drug choice
  22. Path rejoins step 10Shared downstream outcome
  23. Other organism
  24. 17Action

    Other organism (Enterococcus, anaerobes, mixed growth): targeted therapy

    Treat by susceptibility with ID advice.

    • Mycobacteria or fungi: outside this pathway; ID advice for drug choice and duration
  25. Path rejoins step 10Shared downstream outcome
  26. No growth
  27. 18Action

    Culture negative: review the diagnosis

    Continue empiric therapy while septic arthritis is still likely.

    • Antibiotics before aspiration: ask the lab for synovial PCR
    • Gonococcal NAAT (genital, rectal, throat swabs or urine)
    • Consider crystal arthritis, reactive arthritis, and TB if the course is subacute
    • ID advice on duration
  28. Path rejoins step 10Shared downstream outcome

Guideline Source

EBJIS guideline for management of septic arthritis in native joints (SANJO), 2023

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Adults with a native joint only. Children and prosthetic joint infection need other pathways.
  • Tropical northern Australia: melioidosis needs meropenem; TB and fungal arthritis need specialist regimens.
  • Empiric antibiotic choice depends on local resistance and eTG; duration is set with ID advice.
  • Evidence for total duration and IV-to-oral timing is limited (SANJO grade D).

Contraindicated Populations

Children (under 18 years): use a paediatric bone and joint infection pathway (PIDS/IDSA 2023)Prosthetic joint infection: orthopaedic and ID referral; prosthetic joint infection pathway (IDSA 2013)

Applicable Regions

AUEUUS

AU: Empiric and targeted choices follow Therapeutic Guidelines (eTG Antibiotic) and local resistance. Nafcillin is not available; use flucloxacillin or cefazolin. Tropical north: consider melioidosis (meropenem). Gonorrhoea: ASHM dual therapy with azithromycin.

EU: SANJO 2023 (EBJIS): choose empiric therapy by local epidemiology; without resistance risk and with a negative Gram stain, SANJO suggests cloxacillin or cefazolin plus ceftriaxone, or amoxicillin-clavulanate alone.

US: Flucloxacillin is not available; use cefazolin, nafcillin or oxacillin for MSSA. Disseminated gonococcal infection: CDC STI Treatment Guidelines 2021.

Version 2Next review: 2027-09-30

Frequently Asked Questions

What is the Septic Arthritis Management?

The Septic Arthritis Management is a emergency clinical algorithm for Infectious Disease. It provides a structured decision tree to guide clinical decision-making, based on EBJIS guideline for management of septic arthritis in native joints (SANJO), 2023.

What guideline is the Septic Arthritis Management based on?

This algorithm is based on EBJIS guideline for management of septic arthritis in native joints (SANJO), 2023 (DOI: 10.5194/jbji-8-29-2023).

What are the limitations of the Septic Arthritis Management?

Known limitations include: Adults with a native joint only. Children and prosthetic joint infection need other pathways.; Tropical northern Australia: melioidosis needs meropenem; TB and fungal arthritis need specialist regimens.; Empiric antibiotic choice depends on local resistance and eTG; duration is set with ID advice.; Evidence for total duration and IV-to-oral timing is limited (SANJO grade D).. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Septic Arthritis Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free